Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Delfi Diagnostics Inc.
Navigation Sciences, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Ambu A/S
Carebot s.r.o.
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Qmed Consulting A/S
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Mereo BioPharma
Jiangsu HengRui Medicine Co., Ltd.
AVEO Pharmaceuticals, Inc.
Sanofi
Nycomed
Apeiron Biologics